Harmony Biosciences Holdings, Inc.
HRMYHarmony Biosciences is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological diseases.
Earnings
Next report
Aug 4, 2026 (In 6 days)Valuation & ratios
Segments
By segment
Competitors
By market cap
By revenue growth
By net margin
Profile
Harmony Biosciences is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological diseases. The company's core value proposition centers on its sleep/wake franchise, led by a first-in-class therapy that enhances histamine signaling in the brain without being classified as a controlled substance. Harmony is actively expanding its portfolio into rare epilepsy and neurobehavioral disorders through strategic acquisitions and licensing agreements.
Harmony holds a unique market position with the only FDA-approved narcolepsy treatment that is not a DEA-scheduled controlled substance.
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s market cap?
- Harmony Biosciences Holdings, Inc. (HRMY) has a market capitalization of $2.1B and trades on NASDAQ.
- What is Harmony Biosciences Holdings, Inc.'s revenue and profitability?
- Harmony Biosciences Holdings, Inc. generated $899.1M in trailing twelve-month revenue with net income of $145.6M, representing a net margin of 16.2%. Gross margin stands at 76.5%. These figures are based on the Q1 2026 filing.
- Who are Harmony Biosciences Holdings, Inc.'s competitors?
- Harmony Biosciences Holdings, Inc.'s key competitors include Jazz Pharmaceuticals, Axsome Therapeutics, Amneal Pharmaceuticals, and others. These companies compete in similar markets and product categories.
- Who does Harmony Biosciences Holdings, Inc. partner with?
- Harmony Biosciences Holdings, Inc.'s notable partners include Bioprojet Société Civile de Recherche, CiRC Biosciences, Inc., Teijin Pharma, and others.
- What subsidiaries does Harmony Biosciences Holdings, Inc. have?
- Harmony Biosciences Holdings, Inc.'s subsidiaries include Harmony Biosciences, LLC, Harmony Biosciences Management, Inc., Epygenix Therapeutics, Inc., and others.
- Where is Harmony Biosciences Holdings, Inc. headquartered?
- Harmony Biosciences Holdings, Inc. is headquartered in United States of America and employs approximately 246 people. It has been publicly traded since 2020.
